Biomarkers as Indicators for Early Diagnosis of Alzheimer’s Disease: An In-Depth Study
DOI:
https://doi.org/10.47611/jsrhs.v13i4.8242Keywords:
Alzheimer's, Biomarkers, Neurodegenerative Diseases, Treatments, MemoryAbstract
Alzheimer's disease affects millions of people worldwide and is the most common form of dementia. The risk of developing Alzheimer’s increases with age. This neurodegenerative disease is characterized by the deterioration of memory and cognitive functions. Not only does Alzheimer's affect the mental health of patients, but it also affects their immediate family members and caretakers. The later stages of Alzheimer's disease can change the behavior of a person in various ways. Rather than having to witness a family member change so quickly, people often wish they had known that they had AD earlier. Many studies have been conducted regarding methods to predict the development of Alzheimer's disease; however, nothing has been proven definite. One method that has not been discussed enough is the use of biomarkers. Over the years, multiple biomarkers have had success in predicting other major diseases like heart disease, cancer, and diabetes. They are currently being studied for their use in neurological issues. While analyzing multiple studies, this paper aims to establish the effectiveness of using biomarkers to predict signs of Alzheimer’s disease. Ultimately, being able to predict Alzheimer's early on will allow the medical industry to create prevention strategies for the future, along with better treatments.
Downloads
References or Bibliography
Alzheimer’s Association. (n.d.). What Are the Causes and Risk Factors of Alzheimer’s
and Other Dementias? Alzheimer’s Association.
https://www.alz.org/alzheimers-dementia/what-is-alzheimers/causes-and-risk-factors
Andel, R., Vigen, C., Mack, W., Clark, L. J., & Gatz, M. (2006). The effect of education
and occupational complexity on rate of cognitive decline in Alzheimer’s patients. Journal of the International Neuropsychological Society.
https://www.researchgate.net/publication/7339482_The_effect_of_education_and_occup ational_complexity_on_rate_of_cognitive_decline_in_Alzheimer's_patients
Anoop, A., Singh, P. K., Jacob, R. S., & Maji, S. K. (2010). CSF biomarkers for
Alzheimer’s disease diagnosis. International Journal of Alzheimer’s Disease.
https://onlinelibrary.wiley.com/doi/full/10.4061/2010/606802
Ashton, N. J., Schöll, M., Heurling, K., Gkanatsiou, E., Portelius, E., Höglund, K.,
Brinkmalm, G., Hye, A., Blennow, K., & Zetterberg, H. (2018). Update on biomarkers for amyloid pathology in Alzheimer’s disease. Biomarkers in Medicine.
Briggs, R., Kennelly, S. P., & O’Neill, D. (2016). Drug treatments in
Alzheimer’s disease. Clinical Medicine.
https://www.sciencedirect.com/science/article/pii/S1470211824026812
Burholt, V., Windle, G., & Morgan, D. J. (2016). A social model of loneliness: the roles
of disability, social resources, and cognitive impairment. The Gerontologist.
https://academic.oup.com/gerontologist/article/57/6/1020/2452336?login=false
Centers for Disease Control and Prevention. (2013). Mortality From Alzheimer’s Disease in
the United States: Data for 2000 and 2010. Centers for Disease Control and Prevention.
https://www.cdc.gov/nchs/products/databriefs/db116.htm
Chang, C., Lin, C., & Lane, H. (2021). Machine learning and novel biomarkers for the diagnosis of Alzheimer’s
disease. International Journal of Molecular Sciences.
https://www.mdpi.com/1422-0067/22/5/2761#B52-ijms-22-02761
Chen, R., Wilson, K., Chen, Y., Zhang, D., Qin, X., He, M., Hu, Z., Ma, Y., & Copeland,
J. R. (2012). Association between environmental tobacco smoke exposure and dementia syndromes. Occupational and Environmental Medicine.
https://oem.bmj.com/content/70/1/63.short
Gilley, D. W., Wilson, R. S., Beckett, L. A., & Evans, D. A. (1997). Psychotic symptoms
and physically aggressive behavior in Alzheimer’s disease. Journal of the American Geriatrics Society.
https://agsjournals.onlinelibrary.wiley.com/doi/abs/10.1111/j.1532-5415.1997.tb05969.x
Kierny, M., Cunningham, T. D., & Kay, B. K. (2012). Detection of biomarkers
using recombinant antibodies coupled to nanostructured platforms. Nano Reviews.
Lyketsos, C. G., & Olin, J. (2002). Depression in Alzheimer’s disease: overview
and treatment. Biological Psychiatry.
https://www.sciencedirect.com/science/article/abs/pii/S0006322302013483
Mitchell, M. B. (2009). POTENTIAL BIOMARKERS FOR ALZHEIMER’S DISEASE AND MILD COGNITIVE
IMPAIRMENT. The University of Georgia.
https://getd.libs.uga.edu/pdfs/mitchell_meghan_b_200905_phd.pdf
O’Connell, G. C., Alder, M. L., Smothers, C. G., & Chang, J. H. C. (2020).
Large-scale informatic analysis to algorithmically identify blood biomarkers of neurological damage. Proceedings of the National Academy of Sciences.
https://www.pnas.org/doi/10.1073/pnas.2007719117#sec-3
Perneczky, R., Jessen, F., Grimmer, T., Levin, J., Flöel, A., Peters, O., & Froelich, L.
(2023). Anti-amyloid antibody therapies in Alzheimer’s disease. Brain.
https://academic.oup.com/brain/article/146/3/842/6991820?login=false
Povova, J., Ambroz, P., Bar, M., Pavukova, V., Sery, O., Tomaskova, H., & Janout, V.
(2012). Epidemiological of and risk factors for Alzheimer’s disease: A review. Biomedical Papers.
https://pdfs.semanticscholar.org/1830/50a9a5e5090a34405293d1f6862ae48856dd.pdf
Rahman, M. A., Rahman, M. S., Uddin, M. J., Mamum-Or-Rashid, A. N. M., Pang, M., & Rhim, H. (2020).
Emerging risk of environmental factors: insight mechanisms of
Alzheimer’s diseases. Environmental Science and Pollution Research.
https://link.springer.com/article/10.1007/s11356-020-08243-z
Russ, T. C., Batty, G. D., Hearnshaw, G. F., Fenton, C., & Starr, J. M.
(2012). Geographical variation in dementia: systematic review with meta-analysis. International Journal of Epidemiology. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3429875/
Selleck, M. J., Senthil, M., & Wall, N. R. (2017). Making meaningful clinical
use of biomarkers. Biomarker Insights.
https://journals.sagepub.com/doi/full/10.1177/1177271917715236
Shimizu, S., Hirose, D., Hatanaka, H., Takenoshita, N., Kaneko, Y., Ogawa, Y.,
Sakurai, H., & Hanyu, H. (2018). Role of neuroimaging as a biomarker for neurodegenerative diseases. Frontiers in Neurology.
https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2018.00265/full
Simrén, J., Leuzy, A., Karikari, T. K., Hye, A., Benedet, A. L., Lantero‐rodriguez, J.,
Mattsson‐carlgren, N., Schöll, M., Mecocci, P., Vellas, B., Tsolaki, M., Kloszewska, I., Soininen, H., Lovestone, S., Aarsland, D., Hansson, O., Rosa‐neto, P., Westman, E., Blennow, K., Ashton, N. J. (2021). The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer’s disease. Alzheimer’s & Dementia.
https://alz-journals.onlinelibrary.wiley.com/doi/full/10.1002/alz.12283
Vilatela, M. E. A., López-López, M., & Yescas-Gómez, P. (2012). Genetics of
Alzheimer’s Disease. Archives of Medical Research.
https://www.sciencedirect.com/science/article/abs/pii/S0188440912002998
Wang, C., Yu, J., Wang, H., Jiang, T., Tan, C., Meng, X., Soares, H. D., & Tan, L. (2014).
Meta-Analysis of peripheral blood apolipoprotein E levels in Alzheimer’s Disease. PLOS ONE.
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0089041
Yao, W., Yang, H., & Yang, J. (2022). Small-molecule drugs development for
Alzheimer’s disease. Frontiers in Aging Neuroscience.
https://www.frontiersin.org/journals/aging-neuroscience/articles/10.3389/fnagi.2022.1019412/full
Young, P. N. E., Estarellas, M., Coomans, E., Srikrishna, M., Beaumont, H., Maass,
A., Venkataraman, A. V., Lissaman, R., Jiménez, D., Betts, M. J., McGlinchey, E., Berron, D., O’Connor, A., Fox, N. C., Pereira, J. B., Jagust, W., Carter, S. F., Paterson, R. W., & Schöll, M. (2020). Imaging biomarkers in neurodegeneration: current and future practices. Alzheimer’s Research & Therapy.
https://alzres.biomedcentral.com/articles/10.1186/s13195-020-00612-7
Zhang, J., Zheng, X., & Zhao, Z. (2023). A systematic review and meta-analysis on the
efficacy outcomes of selective serotonin reuptake inhibitors in depression in Alzheimer’s disease. BMC
Neurology.
Published
How to Cite
Issue
Section
Copyright (c) 2024 Riddhi Motla; Dr. Kathryn Wilwohl, Professor Virgel Torremocha, Jothsna Kethar
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright holder(s) granted JSR a perpetual, non-exclusive license to distriute & display this article.
